- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06043271
A Single Session Parenting Intervention for Children on a Outpatient Therapy Waitlist
A Single Session Parenting Intervention Administered to Parents of Children Waiting to Receive Cognitive Behavioral Therapy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Anxiety disorders affect as many as 30% of youth and are associated with academic and social impairment and onset of comorbid mood and substance use disorders. Cognitive Behavioral Therapy (CBT) is the treatment of choice for anxiety, achieving remission rates of 60% alone or 80% in combination with medication. However, up to 80% of youth with anxiety disorders do not access the services they need. CBT clinics nationwide have extremely long waits, on the order of 10-12 months. This leads to a vicious cycle, as children waiting for care experience worsening symptoms and decreased motivation, so that by the time they access care, their needs are more intensive and the treatment lasts longer and it takes longer for new children to be able to be assigned.
One proposed pathway to increase access to mental health services is through the delivery of single session interventions (SSIs). SSIs are defined as structured programs that involve one visit or mental health encounter. SSIs are brief, scalable, and there is extensive evidence demonstrating that they can decrease anxiety among children and adolescents recruited from the general community. Importantly, SSIs can be delivered in a self-guided online format. Thus, they are flexible in delivery and content and uniquely suited to be implemented in an outpatient mental health setting for patients on long outpatient therapy waitlists.
One such SSI is the online, self-guided, EMPOWER Program. This SSI takes 30 minutes and targets parent accommodation, a tendency to facilitate avoidance and enable anxious coping that has been shown to maintain and worsen child anxiety and OCD. This SSI has shown promise in reducing parent accommodation of children's anxiety in non-clinical community samples. However, it has not yet been tested among children seeking psychotherapy services who present with higher acuity. Thus, the goal of this project is to test the EMPOWER SSI delivered to parents of children on the waitlist for outpatient CBT. Parent participants will be randomized to either the SSI or to remain on the waitlist as usual for monitoring. The investigators predict that parents who receive the SSI, compared to the control group, will report (a) greater reductions in accommodation from baseline to 2-week follow-up. As a secondary hypothesis, the investigators will explore whether children of parents who received the SSI will show more rapid improvements in anxiety symptoms over the first 6 months of CBT.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Parents will be eligible to participate if:
- Their child has anxiety and/or Obsessive-Compulsive Disorder (OCD) (either subclinical or clinical), as determined by an initial screening
- Their child is between the age of 5 and 12 years-old
- Parents are English-speaking
- Parents are over the age of 18 years old
Exclusion Criteria:
Parents will be excluded if:
- Their child shows symptoms of suicidal or homicidal ideation, psychosis, or primary severe mood or behavior disorder (i.e., if treatment for another disorder other than anxiety is indicate prior to treatment for anxiety)
- Their child is already receiving CBT (i.e., transfer cases from other CBT providers in the community).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: The EMPOWER Program
The EMPOWER Program (Sung et al., 2021) is a web-based, self-administered SSI for parents that takes about 30 minutes to complete.
The SSI includes 5 elements based on the components of CBT.
|
The EMPOWER Program is a web-based, self-administered SSI for parents that takes about 30 minutes to complete.
Other Names:
|
|
No Intervention: Waitlist as Usual
Participants in the control group will have their children remain on the waitlist until they are assigned to a therapist in the clinic.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Pediatric Accommodation Scale, Parent-Report
Time Frame: Baseline to 2-week follow up
|
The Pediatric Accommodation Scale is a parent-report of accommodation of their offspring's anxiety.
Parents are asked to rate, on a 5-point scale from 0 (never) to 5 (always), the extent to which they accommodate their child's anxiety or avoidance behaviors.
Total scores range from 0 to 25, with higher scores reflecting greater parental accommodation.
Parents will report on their accommodation behaviors at baseline and 2-weeks follow-up.
|
Baseline to 2-week follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Spence Child Anxiety Scale, Parent-Report Total score
Time Frame: Baseline to 2-week follow up; Change over first 6 months of CBT (intake to 3- and 6-month follow-up)
|
The Spence Child Anxiety Scale is a 38 item parent-report assessment of child anxiety symptoms.
Parents are asked to rate on a 4-point scale (0-3) the presence of different anxiety symptoms in their children.
Items are summed and higher scores reflect more severe child anxiety symptoms.
Parents will report on their children's anxiety symptoms at baseline and 2-week follow-up.
After children from the waitlist are assigned to a therapist to begin CBT, parents will complete this questionnaire prior to treatment onset (intake), and at 3- and 6-months follow-up.
|
Baseline to 2-week follow up; Change over first 6 months of CBT (intake to 3- and 6-month follow-up)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023P001725
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety Disorders
-
University of CalabriaNot yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking AnxietyItaly
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiActive, not recruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Abant Izzet Baysal UniversityRecruitingAnxiety | Parental AnxietyTurkey (Türkiye)
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; Boston University; Johns Hopkins... and other collaboratorsCompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety DisordersUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
University of Colorado, BoulderEnrolling by invitationStress | Anxiety | Social AnxietyUnited States
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
Institut National de la Santé Et de la Recherche...Active, not recruitingAnxiety Disorders | Anxiety | Anxiety and FearFrance
-
Loyola UniversityCompletedAnxiety | Anxiety State | Procedural AnxietyUnited States
Clinical Trials on The EMPOWER Program
-
Yale UniversityNational Center for Advancing Translational Sciences (NCATS); Academic Pediatric...CompletedSocial Emotional WellnessUnited States
-
Göteborg UniversityKarolinska University Hospital; The Swedish Research Council; Swedish Council... and other collaboratorsActive, not recruiting
-
Population CouncilWorld Bank; International Rescue Committee; City University of New YorkUnknownSexual Violence | Adolescent BehaviorLiberia
-
Bio Nature HealthCitruslabsCompletedEye Health | Eye Dryness | Inflammation SymptomsUnited States
-
University of GeorgiaNational Institute of Mental Health (NIMH)Not yet recruitingHIV Pre-exposure ProphylaxisUnited States
-
University of RochesterWithdrawnHeart FailureUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
University of Missouri-ColumbiaEnrolling by invitation
-
Pace UniversityNot yet recruitingChronic Disease
-
VA Office of Research and DevelopmentCompletedBenzodiazepine Dependence | Taking Benzodiazepines for Any Reason for 3 MonthsUnited States